Park Avenue Securities LLC Acquires Shares of 10,111 SPDR S&P Pharmaceuticals ETF $XPH

Park Avenue Securities LLC bought a new stake in shares of SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund bought 10,111 shares of the company’s stock, valued at approximately $485,000. Park Avenue Securities LLC owned 0.27% of SPDR S&P Pharmaceuticals ETF at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Advantage Trust Co grew its holdings in SPDR S&P Pharmaceuticals ETF by 1,525.0% in the second quarter. Advantage Trust Co now owns 3,250 shares of the company’s stock valued at $132,000 after purchasing an additional 3,050 shares during the period. Envestnet Portfolio Solutions Inc. lifted its position in shares of SPDR S&P Pharmaceuticals ETF by 42.0% during the 2nd quarter. Envestnet Portfolio Solutions Inc. now owns 161,088 shares of the company’s stock valued at $6,537,000 after buying an additional 47,626 shares in the last quarter. Goldman Sachs Group Inc. lifted its position in shares of SPDR S&P Pharmaceuticals ETF by 96.9% during the 1st quarter. Goldman Sachs Group Inc. now owns 119,929 shares of the company’s stock valued at $5,253,000 after buying an additional 59,007 shares in the last quarter. JPMorgan Chase & Co. grew its stake in SPDR S&P Pharmaceuticals ETF by 9.4% in the 2nd quarter. JPMorgan Chase & Co. now owns 57,258 shares of the company’s stock valued at $2,324,000 after acquiring an additional 4,918 shares during the period. Finally, Jane Street Group LLC purchased a new stake in SPDR S&P Pharmaceuticals ETF in the 1st quarter worth $308,000.

SPDR S&P Pharmaceuticals ETF Trading Down 0.6%

Shares of NYSEARCA XPH opened at $55.71 on Friday. The stock has a market cap of $233.98 million, a PE ratio of 14.28 and a beta of 0.60. SPDR S&P Pharmaceuticals ETF has a 12-month low of $35.22 and a 12-month high of $57.58. The company has a 50-day moving average of $54.77 and a 200 day moving average of $48.96.

About SPDR S&P Pharmaceuticals ETF

SPDR S&P Pharmaceuticals ETF (the Fund) seeks to replicate as closely as possible the total return performance of the S&P Pharmaceuticals Select Industry Index. The S&P Pharmaceuticals Select Industry Index represents the pharmaceuticals sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.